Workflow
机构风向标 | 瑞普生物(300119)2025年二季度已披露前十大机构持股比例合计下跌1.97个百分点

Core Insights - Reap Bio (300119.SZ) released its semi-annual report for 2025, indicating that as of August 25, 2025, 10 institutional investors held a total of 24.3797 million A-shares, representing 5.25% of the company's total equity [1] - The top ten institutional investors include notable entities such as Hong Kong Central Clearing Limited and various private equity funds, with a combined holding ratio that decreased by 1.97 percentage points compared to the previous quarter [1] Institutional Holdings - Among public funds, there was an increase in holdings from one fund, the Guotai CSI Animal Husbandry ETF, while two funds, including the Harvest Agricultural Industry Stock A and Guotai Location Advantage Mixed A, saw a decrease in holdings by 0.66% [2] - Four new public funds disclosed their holdings this period, including Chang'an Xinyue Consumer Mixed A and others, while 17 public funds were not disclosed this period, including notable funds like Penghua Quality Governance Mixed (LOF) A [2] - For social security funds, one fund, the Huatai-PineBridge Fund Management Co., Ltd. - Social Security Fund 423 Combination, was not disclosed this period [2] - Foreign investment sentiment showed an increase in holdings from one foreign fund, Hong Kong Central Clearing Limited, with a holding increase of 0.37% [2]